Abdominal aortic aneurysm (AAA) is a potentially fatal vascular disorder with a high mortality rate. It was previously reported that fibroblast growth factor 21 (FGF21) was highly expressed in AAA patients. Nonetheless, its underlying mechanism in AAA progression is unclarified.
Methods
Angiotensin II (Ang-II) was used to induce AAA in human aortic vascular smooth muscle cells (HASMCs) and mouse models. Western blotting and RT-qPCR were utilized for measuring protein and RNA levels. Immunofluorescence staining was utilized for detecting LC3B expression in HASMCs. Elastica van Gieson staining was conducted for histological analysis of the abdominal aortas of mice.
Results
FGF21 displayed a high level in Ang-II-stimulated HASMCs and AAA mice. FGF21 depletion ameliorated abdominal aorta dilation and Ang-II-triggered pathological changes in mice. FGF21 silencing hindered autophagy and PI3K/AKT/mTOR pathway.
Conclusions
FGF21 contributes to AAA progression by enhancing autophagy and activating PI3K/AKT/mTOR pathway.
StepienKLBajdak-RusinekKFus-KujawaA, et al.Role of extracellular matrix and inflammation in abdominal aortic aneurysm. Int J Mol Sci2022; 23: 2022/10. DOI: 10.3390/ijms231911078.
2.
TianZZhangYZhengZ, et al.Gut microbiome dysbiosis contributes to abdominal aortic aneurysm by promoting neutrophil extracellular trap formation. Cel hos micr2022; 30: 1450-1463. DOI: 10.1016/j.chom.2022.09.004.
3.
HaqueKBhargavaP. Abdominal aortic aneurysm. Am Fam Physician2022; 106: 165–172.
4.
ThanigaimaniSIbrahimMGolledgeJ. Potential of disease-modifying anti-rheumatic drugs to limit abdominal aortic aneurysm growth. Biomedicines2022; 10: 2409. DOI: 10.3390/biomedicines10102409.
5.
BainsPOliffeJLMackayMH, et al.Screening older adult men for abdominal aortic aneurysm: a scoping review. Am J Men’s Health2021; 15: 15579883211001204. DOI: 10.1177/15579883211001204.
6.
MaXXiaSLiuG, et al.The detrimental role of intraluminal thrombus outweighs protective advantage in abdominal aortic aneurysm pathogenesis: the implications for the anti-platelet therapy. Biomolecules2022; 12: 942. DOI: 10.3390/biom12070942.
7.
IsselbacherEMPreventzaOHamilton Black IiiJ, et al.2022ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol2022; 80: e223–e393. DOI: 10.1016/j.jacc.2022.08.004.
8.
LiuSLiaoYLiuC, et al.Identification of a miRSNP regulatory axis in abdominal aortic aneurysm by a network and pathway-based integrative analysis. Oxid Med Cell Longev2022; 2022: 8776566. DOI: 10.1155/2022/8776566.
9.
SweetingMJThompsonSGBrownLC, et al.Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms. Br J Surg2012; 99: 655-665. DOI: 10.1002/bjs.8707.
10.
HensleySEUpchurchGRJr.Repair of abdominal aortic aneurysms: JACC focus seminar, Part 1. J Am Coll Cardiol2022; 80: 821-831. DOI: 10.1016/j.jacc.2022.04.066.
GuoJWangZXueM, et al.Metformin protects against abdominal aortic aneurysm by Atg7-induced autophagy. Adv Clin Exp Med : Official Organ Wroclaw Medical University2022; 31: 59–69. DOI: 10.17219/acem/142026.
14.
ChenGXuYYaoY, et al.IKKε knockout alleviates angiotensin II-induced apoptosis and excessive autophagy in vascular smooth muscle cells by regulating the ERK1/2 pathway. Exp Ther Med2021; 22: 1051. DOI: 10.3892/etm.2021.10485.
15.
WangZGuoJHanX, et al.Metformin represses the pathophysiology of AAA by suppressing the activation of PI3K/AKT/mTOR/autophagy pathway in ApoE(-/-) mice. Cell Biosci2019; 9: 68. DOI: 10.1186/s13578-019-0332-9.
16.
WuAFengBYuJ, et al.Fibroblast growth factor 21 attenuates iron overload-induced liver injury and fibrosis by inhibiting ferroptosis. Redox Biol2021; 46: 102131. DOI: 10.1016/j.redox.2021.102131.
17.
XiaolongLDongminGLiuM, et al.FGF21 induces autophagy-mediated cholesterol efflux to inhibit atherogenesis via RACK1 up-regulation. J Cell Mol Med2020; 24: 4992–5006. DOI: 10.1111/jcmm.15118.
18.
LiXZhangYSuL, et al.FGF21 alleviates pulmonary hypertension by inhibiting mTORC1/EIF4EBP1 pathway via H19. J Cell Mol Med2022; 26: 3005–3021. DOI: 10.1111/jcmm.17318.
19.
XieTYinLGuoD, et al.The potential role of plasma fibroblast growth factor 21 as a diagnostic biomarker for abdominal aortic aneurysm presence and development. Life Sci2021; 274: 119346. DOI: 10.1016/j.lfs.2021.119346.
20.
TaoKLiMGuX, et al.Activating transcription factor 4 aggravates angiotensin II-induced cell dysfunction in human vascular aortic smooth muscle cells via transcriptionally activating fibroblast growth factor 21. Korean J Physiol Pharmacol : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology2022; 26: 347–355. DOI: 10.4196/kjpp.2022.26.5.347..
21.
ZhengJMaXZhouY, et al.GATA2/FGF21 axis regulates the effects of high glucose on the apoptosis, autophagy and oxidative stress of human umbilical vein endothelial cell via PI3K/AKT/mTOR pathway. Anna clin labora scie2022; 52: 278–291.
22.
DaiHHuWZhangL, et al.FGF21 facilitates autophagy in prostate cancer cells by inhibiting the PI3K-Akt-mTOR signaling pathway. Cell Death Dis2021; 12: 303. DOI: 10.1038/s41419-021-03588-w.
23.
ZhangXJHeCTianK, et al.Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways. Vasc Pharmacol2015; 73: 86–95. DOI: 10.1016/j.vph.2015.04.003.
24.
ZhangZZouGChenX, et al.Knockdown of lncRNA PVT1 Inhibits vascular smooth muscle cell apoptosis and extracellular matrix disruption in a murine abdominal aortic aneurysm model. Mol Cell2019; 42: 218-227. DOI: 10.14348/molcells.2018.0162.
25.
AmiokaNMiyoshiTYonezawaT, et al.Pemafibrate prevents rupture of angiotensin ii-induced abdominal aortic aneurysms. Fronti Cardiovas Medic2022; 9: 904215. DOI: 10.3389/fcvm.2022.904215.
26.
AzumaJMaegdefesselLKitagawaT, et al.Assessment of elastase-induced murine abdominal aortic aneurysms: comparison of ultrasound imaging with in situ video microscopy. J Biomed Biotechnol2011; 2011: 252141. DOI: 10.1155/2011/252141.
27.
DaiMZhuXZengS, et al.Dexmedetomidine protects cells from Angiotensin II-induced smooth muscle cell phenotype switch and endothelial cell dysfunction. Cell Cycle2023; 22: 450–463, DOI:10.1080/15384101.2022.2124489.
28.
GaoRGuoWFanT, et al.Phosphodiesterase 4D contributes to angiotensin II-induced abdominal aortic aneurysm through smooth muscle cell apoptosis. Exp Mol Med2022; 54: 1201–1213. DOI: 10.1038/s12276-022-00815-y.
GengLLamKSLXuA. The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic. Nat Rev Endocrinol2020; 16: 654–667. DOI: 10.1038/s41574-020-0386-0.
31.
ByunSSeokSKimYC, et al.Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase. Nat Commun2020; 11: 807. DOI: 10.1038/s41467-020-14384-z.
32.
WangLLiuSPanB, et al.The role of autophagy in abdominal aortic aneurysm: protective but dysfunctional. Cell Cycle2020; 19: 2749–2759. DOI: 10.1080/15384101.2020.1823731.
33.
RamadanAAl-OmranMVermaS. The putative role of autophagy in the pathogenesis of abdominal aortic aneurysms. Atherosclerosis2017; 257: 288–296. DOI: 10.1016/j.atherosclerosis.2017.01.017.
34.
BjørkøyGLamarkTPankivS, et al.Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol2009; 452: 181–197. DOI: 10.1016/s0076-6879(08)03612-4.
35.
ZhouKChenHLinJ, et al.FGF21 augments autophagy in random-pattern skin flaps via AMPK signaling pathways and improves tissue survival. Cell Death Dis2019; 10: 872. DOI: 10.1038/s41419-019-2105-0.
36.
LiuQShanPLiH. Gambogic acid prevents angiotensin II-induced abdominal aortic aneurysm through inflammatory and oxidative stress dependent targeting the PI3K/Akt/mTOR and NF-κB signaling pathways. Mol Med Rep2019; 19: 1396–1402. DOI: 10.3892/mmr.2018.9720.
